Phase II Study Of Arsenic Trioxide In Patients With Refractory Germ Cell Malignancies.
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Arsenic trioxide (Primary)
- Indications Germ cell cancer; Testicular cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 13 Jun 2007 Status changed from in progress to completed
- 17 Sep 2005 New trial record.